These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 16982229

  • 1. Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling.
    Shaarawy M, El-Mallah SY, Seoudi S, Hassan M, Mohsen IA.
    Contraception; 2006 Oct; 74(4):297-302. PubMed ID: 16982229
    [Abstract] [Full Text] [Related]

  • 2. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
    Viola AS, Castro S, Bahamondes MV, Fernandes A, Viola CF, Bahamondes L.
    Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
    [Abstract] [Full Text] [Related]

  • 3. Depot medroxyprogesterone acetate use after peak bone mass is associated with increased bone turnover but no decrease in bone mineral density.
    Walsh JS, Eastell R, Peel NF.
    Fertil Steril; 2010 Feb; 93(3):697-701. PubMed ID: 19013564
    [Abstract] [Full Text] [Related]

  • 4. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
    Clark MK, Sowers MR, Nichols S, Levy B.
    Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
    [Abstract] [Full Text] [Related]

  • 5. Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study.
    Pongsatha S, Ekmahachai M, Chaovisitsaree S, Suntornlimsiri N, Morakote N.
    J Med Assoc Thai; 2009 Oct; 92(10):1263-7. PubMed ID: 19845231
    [Abstract] [Full Text] [Related]

  • 6. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
    Beksinska ME, Smit JA, Kleinschmidt I, Farley TM, Mbatha F.
    Contraception; 2005 Mar; 71(3):170-5. PubMed ID: 15722065
    [Abstract] [Full Text] [Related]

  • 7. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections.
    Harel Z, Johnson CC, Gold MA, Cromer B, Peterson E, Burkman R, Stager M, Brown R, Bruner A, Coupey S, Hertweck P, Bone H, Wolter K, Nelson A, Marshall S, Bachrach LK.
    Contraception; 2010 Apr; 81(4):281-91. PubMed ID: 20227543
    [Abstract] [Full Text] [Related]

  • 8. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.
    Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM.
    Arch Pediatr Adolesc Med; 2005 Feb; 159(2):139-44. PubMed ID: 15699307
    [Abstract] [Full Text] [Related]

  • 9. Bone mineral density and depot medroxyprogesterone acetate.
    Albertazzi P, Bottazzi M, Steel SA.
    Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral density.
    Johnson CC, Burkman RT, Gold MA, Brown RT, Harel Z, Bruner A, Stager M, Bachrach LK, Hertweck SP, Nelson AL, Nelson DA, Coupey SM, McLeod A, Bone HG.
    Contraception; 2008 Apr; 77(4):239-48. PubMed ID: 18342646
    [Abstract] [Full Text] [Related]

  • 11. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
    Kaunitz AM, Darney PD, Ross D, Wolter KD, Speroff L.
    Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
    [Abstract] [Full Text] [Related]

  • 12. Effect of depot medroxyprogesterone acetate on bone mineral density in adolescent women.
    Zhang MH, Zhang W, Zhang AD, Yang Y, Gai L.
    Chin Med J (Engl); 2013 Nov; 126(21):4043-7. PubMed ID: 24229671
    [Abstract] [Full Text] [Related]

  • 13. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

  • 14. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate.
    Clark MK, Sowers M, Levy B, Nichols S.
    Fertil Steril; 2006 Nov; 86(5):1466-74. PubMed ID: 16996507
    [Abstract] [Full Text] [Related]

  • 15. Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
    Sanches L, Marchi NM, Castro S, Juliato CT, Villarroel M, Bahamondes L.
    Contraception; 2008 Nov; 78(5):365-9. PubMed ID: 18929732
    [Abstract] [Full Text] [Related]

  • 16. Bone mineral density, fracture, and vitamin D in adolescents and young women using depot medroxyprogesterone acetate.
    Pitts SA, Feldman HA, Dorale A, Gordon CM.
    J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):23-6. PubMed ID: 22078997
    [Abstract] [Full Text] [Related]

  • 17. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
    Kaunitz AM.
    Int J Fertil Womens Med; 1998 Feb; 43(2):73-83. PubMed ID: 9609206
    [Abstract] [Full Text] [Related]

  • 18. Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.
    Kaunitz AM, Miller PD, Rice VM, Ross D, McClung MR.
    Contraception; 2006 Aug; 74(2):90-9. PubMed ID: 16860045
    [Abstract] [Full Text] [Related]

  • 19. Long-term assessment of forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
    Viola AS, Castro S, Marchi NM, Bahamondes MV, Viola CF, Bahamondes L.
    Contraception; 2011 Aug; 84(2):122-7. PubMed ID: 21757052
    [Abstract] [Full Text] [Related]

  • 20. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone.
    Han KO, Choi JT, Choi HA, Moon IG, Yim CH, Park WK, Yoon HK, Han IK.
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):349-53. PubMed ID: 15730418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.